ABSTRACT. There is a constant search for new cancer treatments that are less aggressive and economically affordable. In this context, natural products extracted from plants, fungi, and microorganisms are of great interest. Pestheic acid, or dihidromaldoxin, is a chlorinated diphenylic ether extracted from the phytopathogenic fungus Pestalotiopsis guepinii (Amphisphaeriaceae). We assessed the cytotoxic, cytostatic, and genotoxic effects of pestheic acid in a gastric adenocarcinoma cell line (PG100). A decrease in clonogenic survival was observed. Pestheic acid also induced significant increases in both micronucleus and nucleoplasmic bridge frequency. However, we did not observe changes in cell cycle kinetics or apoptosis induction. Reactive oxygen species induced by diphenylic ethers may explain the genotoxicity and mutagenicity of pestheic acid. The absence of repair checkpoints that we observed is probably due to the fact that the PG100 cell line lacks the TP53 gene, which is common in gastric cancers. Even though pestheic acid has had a clear cytotoxic effect, the minimal inhibitory concentration was high, which shows that pestheic acid is not an active anticancer compound under these conditions.
INTRODUCTION
The use of natural compounds, obtained from plants and fungi, for the treatment, cure, and prevention of diseases is one of the most ancient practices in medicine (Balunas and Kinghorn, 2005; Turolla and Nascimento, 2006) . Chemotherapy is one of the main types of treatment for some malignancies. Therefore, it is extremely important to identify, extract, and synthesize compounds obtained from nature that can be used in the treatment of some neoplasias. Studies have focused on such activities in search of new substances that have the capacity to inhibit cell proliferation and metastasis (Suda et al., 2006; Yoshikawa et al., 2006) .
Brazil has a rich fauna and flora, with a particular potential to produce natural compounds that can be used as medications in the prophylaxis, treatment, and cure of a wide range of pathologies, including fungal infections, diabetes, high cholesterol levels, and some kinds of cancers (Farias et al., 1997; Pinto et al., 2002; Cragg and Newman, 2005) . Therefore, natural resources such as fungi are an important source of natural bioactive compounds (Wall and Wani, 1996) . Some important anticancer drugs developed from fungi include those from the class of anthracyclines, bleomycins, actinomycins, and mitomycins (Culliname et al., 1994) .
Aiming to evaluate the effect that some substances extracted from different fungi species found in that Amazonian flora have on neoplastic cells, our research group isolated different compounds from the endophyte species Pestalotiopsis guepinii. P. guepinii lives in association with Virola michelii, an abundant plant in the Amazon rainforest, easily found around the Belém (State of Pará) area and traditionally known as "ucuúba preta". V. michelii leaves are used by the people of this region as a medicine to ease skin rashes caused by fungi (Schultes and Holmstedt, 1968) . From P. guepinii biomass, we isolated and identified different substances, including pestheic acid.
Pestheic acid, or dihydromaldoxin, is a chlorinated diphenyl ether isolated in 1996 by Adeboya et al., which acts as a plant growth regulator (Shimada et al., 2001) . Its cytotoxic and genotoxic properties in eukaryote cells are still unknown. There is evidence, however, that diphenyl ethers exert different genotoxic effects in mammalian cells. Bolognesi et al. (2006) evaluated the genotoxic properties of tetrabromodiphenyl ether in fish erythrocytes using the micronucleus assay and found a statistically significant increase in micronucleus frequency, as well as an increase in the frequency of nuclear abnormalities. On the other hand, Evandri et al. (2003) did not observe any cytotoxic and/or genotoxic effects induced by the diphenyl ether BDE-99 using the chromosomal aberration test in Allium cepa.
The present study aimed to evaluate the cytotoxic, cytostatic, and mutagenic effects of pestheic acid in a gastric cancer cell line (PG100), since gastric cancer is a very frequent disease in the Amazonian region (Resende et al., 2006) .
MATERIAL AND METHODS

Pestheic acid isolation
The P. guepinii fungus was statically cultured in a 4.5-kg rice medium with 30% humidity at 28ºC for 30 days. Methanol (10 L) was added to this medium and the solid material was removed by filtration. The filtrate was concentrated under reduced pressure to afford 157.3 g of a dark residue. This residue was suspended in 500 mL MeOH:H 2 O (1:3) solution. The suspension was extracted successively with hexane (3 x 1000 mL), dichloromethane (3 x 1000 mL), and EtOAc (3 x 1000 mL) and was further concentrated under vacuum. The EtOAc fraction (4.74 g) was separated by column chromatography on silica gel using mixtures of hexane, ethyl acetate, and methanol in increasing polarities as eluents. After analysis by nuclear magnetic resonance spectroscopy of the subfractions, the hexane:EtOAc (2:8) fraction was submitted to semi-preparative reversed phase high-performance liquid chromatography (250/10 Synergi fusion C18, H 2 O:MeCN 1:1, acidified (1% HCOOH), flow rate 4.7 mL/min, 254 nm) to yield 54.0 mg pestheic acid (Figure 1 ). The spectral data were in agreement with the literature (Adeboya et al., 1996) . 
Cell culture
The PG100 cell line was commercially obtained from the Rio de Janeiro Cell Bank. It was established after primary culture from a gastric resection of a 29-year-old male patient with gastric adenocarcinoma. Cells were grown in HAM F10 + DMEM (Sigma Chemical Co. St. Louis, MO, USA) (1:1) (v/v) supplemented with 15% fetal bovine serum (Gibco, Grand Island, NY, USA), kanamycin (0.1 mg/mL), ciprofloxacin (0.02 mg/mL), streptomycin (0.1 Cellular responses induced by pestheic acid mg/mL), and penicillin (99 U/mL), and were kept in an incubator at 37°C and 5% CO 2 .
Clonogenic survival assay
For these experiments, 1 x 10 6 cells were treated for 24 h with five different pestheic acid concentrations (3.68, 7.36, 14.72, 29.44 and 58 .88 µg/mL + negative control). After treatment, cells were trypsinized and 300 cells of each concentration were transferred to new duplicate culture flasks. Clones were visualized 10 days after treatment. Colonies were washed twice with PBS and then stained with Giemsa in phosphate buffer (1:30) for 50 min. After staining, cells were washed in distilled water and clones were counted. We considered as 100% the number of colonies counted in our negative control group, and the survival fraction (SF) was calculated using the following formula:
No. of clones counted in each treatment x 100
No. of clones in negative control group SF =
Micronucleus assay
Cells (1 x 10 6 ) were treated with pestheic acid for 24 h, after which cytochalasin B (Sigma Chemical Co.) (3 µg/mL) was added and the cells incubated for another 24 h at 37°C. Cells were afterwards harvested by trypsinization and centrifuged, and slides were prepared by dropping the cell suspension directly onto pre-washed slides. Slides were stained in 3% Giemsa (Sigma Chemical Co.) in phosphate buffer (pH 6.8) for 10 min. Micronuclei were scored in 1000 binucleated cells using criteria described elsewhere (Fenech et al., 2003) . We also evaluated the number of nucleoplasmic bridges in 1000 binucleated cells in each treatment. Pestheic acid concentrations used in this assay were 7.36, 14.72 and 28.44 µg/mL. As a positive control, we used doxorubicin at a final concentration of 0.0173 µg/mL.
Assessment of changes in cell cycle kinetics and apoptosis (sub-G1 peak) induction by flow cytometry
For these experiments, 8 x 10 5 cells were treated with 29.44 µg/mL pestheic acid for 24 h at 37°C. Cells were then submitted to the protocol of the Cycle Test tm Plus kit (Becton Dickinson) and subsequently read using a flow cytometer (Becton Dickinson Facs Calibur) 24, 48, and 72 h after treatment. As a positive control, we used doxorubicin at a final concentration of 0.0173 µg/mL.
Statistical analysis
The data were submitted to multiple variance analysis (ANOVA) and the post-hoc Tukey test for the clonogenic survival assay, micronucleus test, and evaluation of nucleoplasmic bridges. A t test was used to assess changes in cell cycle kinetics and apoptosis induction. We also used a non-parametric test (Kruskal-Wallis) when necessary. P < 0.05 was considered statistically significant for all the parameters evaluated. BioEstat 5.0 (Ayres et al., 2007) was used for statistical analysis.
RESULTS
Clonogenic survival assay
Clonogenic survival, assessed 10 days after treatment with pestheic acid, showed a decrease starting at the lowest concentration (3.68 µg/mL; 88.88% survival). Such decrease was statistically significant (P < 0.05) at 29.44 µg/mL (53.96%) and 58.88 µg/mL (33.33%) when compared with the control group (Figure 2 ). Colony survival rates were 88.88, 70.63, 79.36, 53.96, and 33 .33% for pestheic acid concentrations of 3.68, 7.36, 14.72, 29.44 and 58.88 µg/mL, respectively. On the basis of these data, we defined the concentrations of pestheic acid to be used in the micronucleus test, i.e., 7.36, 14.72 and 29.44 µg/mL, since such concentrations showed a survival rate over 50% when compared with the negative control. 
Micronucleus assay and nucleoplasmic bridges
Mean micronuclei per 1000 binucleated cells analyzed were 53, 51.34 and 62 for 7.36, 14.72 and 29.44 µg/mL pestheic acid, respectively. The highest concentration (29.44 µg/mL) showed a statistically significant (P < 0.05) increase in micronucleus (MN) frequency when compared with the negative control (25.34 MN/1000 binucleated cells). Cells treated with doxorubicin (0.0173 µg/mL) had a mean micronucleus frequency of 72.67, which was also statistically significant (P < 0.05) when compared with the control group (25.34 MN/1000 binucleated cells) (Figure 3) .
Mean nucleoplasmic bridges (NPB) per 1000 binucleated cells were 23, 23, and 34 for 7.36, 14.72 and 29.44 µg/mL pestheic acid, respectively. The highest concentration (29.44 µg/mL) induced a significant (P < 0.05) increase in NPB frequency when compared with the control group (17 NPB/1000 binucleated cells). Treatment with doxorubicin (0.0173 µg/mL) induced 40 NPB/1000 binucleated cells, which was also statistically significant (P < 0.05) when compared with the control group (Figure 4 ) (17 NPB/1000 binucleated cells). 
Cell cycle kinetics and apoptosis (sub-G1 peak)
To evaluate the effects of pestheic acid on cell cycle kinetics and apoptosis induction, PG100 cells were treated with 29.44 µg/mL pestheic acid for 24 h. Cells were then evaluated by flow cytometry 24, 48 and 72 h after treatment. In our experimental conditions, pestheic acid did not induce changes in cell cycle kinetics in the cell line tested (Table 1) , nor did it induce apoptosis ( Figure 5 ). Doxorubicin also failed to produce such effects (data not shown).
DISCUSSION
The present study evaluated some cell responses (cytotoxicity, cytostaticity, and mutagenicity) induced by pestheic acid, a metabolite isolated from the fungal species P. guepinii, in a gastric cancer cell line (PG100). So far, no other work with this aim using such compound has been published.
Data from the micronucleus assay and NPB evaluation in PG100 cells after treatment with pestheic acid showed an increase in both parameters when compared with their respective controls (Figures 3 and 4) . Genotoxic and mutagenic properties induced by other diphenyl ethers have also been observed in some studies. Barber et al. (2006) evaluated the mutagenicity of five different polybromated diphenyl ethers (PBDEs 47, 99, 153, 183, and 209 ) using the micronucleus assay in MCF-7 cells (human mammary carcinoma) and found a significant increase in micronucleus frequency after a 24-h treatment with each compound at 10 -9 M. He et al. (2008) studied the mutagenic properties of PBDE-47 in a human neuroblastoma cell line (SH-SY5Y) using the micronucleus assay, and they observed an increase in micronucleus and NPB frequencies at a concentration of 4 µg/mL. According to these authors, a possible mechanism by which diphenyl ethers could enhance recombination or induce chromosomal aberrations is by interfering with chromatin structure and/or the proteins involved in the process.
Another possible mechanism to explain the genotoxic effects of diphenyl ethers Data are reported as means ± SD of three experiments. Table 1 . Distribution of PG100 cells treated with 29.44 µg/mL pestheic acid for 24 h in different phases of the cell cycle. Cells were analyzed at 24, 48, and 72 h after treatment.
would be their capacity to create reactive oxygen species (ROS), which induce DNA damage (Williams and Jeffrey, 2000) . Fernie et al. (2005) analyzed the correlation between different PBDEs and oxidative stress in Falco sparverius cells, and found that PBDEs 47, 99, 100, and 153 induced oxidative stress in those cells, causing an increase in ROS production. Reistad and Mariussen (2005) investigated the effects caused by PBDE-71 on human granulocytes in vitro and observed that this compound increased ROS production in a dose-dependent manner.
The investigation on the effects of pestheic acid on PG100 cell cycle kinetics by flow cytometry showed that this metabolite does not induce changes in this parameter, which means that under the study conditions, pestheic acid does not induce cell cycle arrest for an eventual repair of cellular DNA damage. Pestheic acid did not induce apoptosis in the PG100 cell line in our experimental conditions as well. When DNA is damaged, many different pathways, the function of which is to repair the damage to minimize the occurrence of mutation, are instantly triggered. Such pathways are part of a complex signaling mechanism, each one covering a specific kind of DNA damage. Cells have basically three different responses to DNA damage caused by genotoxic agents: checkpoint activation, DNA repair, or apoptosis induction. Checkpoint activation happens when DNA damage is detected by specific proteins, such as Atm and Atr, which, along with different mediators, transduce signals to other proteins, such as Chk1 and Chk2, which activate or inactivate effector proteins. Effector proteins such p53 and cdc25 inhibit G1/S transition, S-phase progression, or G2/M transition (Sancar et al., 2004; Chen and Poon, 2008; Lazzaro et al., 2009) .
In the present study, although we observed evidence of DNA damage induced by pestheic acid, we did not detect checkpoint activation in response to DNA lesions since neither cell cycle arrest nor apoptosis induction was observed (Table 1 and Figure 5) . A very likely explanation for the absence of classic checkpoint activations would be PG100 possessing a mutated or deleted TP53 gene. Conventional cytogenetic studies performed by our research group using GTG banding showed a deletion in the 17p chromosomal region, where the TP53 gene is located (Ribeiro et al., 2010) . Alterations in such gene are recurrent in gastric cancer (Maesawa et al., 1995; Uchino et al., 1993) . Kobayashi et al. (1996) studied alterations in the TP53 locus in 67 gastric carcinomas using fluorescent in situ hybridization and found a deletion in 39% of the tumors analyzed and loss of heterozygozity of the 17p13.3 band. Functional loss of this gene seems to be associated with deletions of the 17p13.3 region and a nonsense mutation of the remainder allele, representing a starting event of the gastric carcinogenesis process and playing a crucial role in the conversion from adenomas into adenocarcinomas (Uchino et al., 1993) .
The results of the clonogenic survival assay showed that pestheic acid has cytotoxic activity, inducing a decrease in cell survival in a dose-response manner (Figure 2 ) 10 days after the treatment, indicating that such compound induced late cell death in the PG100 cell line. The cytotoxic activities of other diphenyl ethers and their derivates in neoplastic cell lines have been observed by other authors as well. Bunyapaiboonsri et al. (2007) isolated two new glycosidic diphenyl ethers (cordyol A and B) and a diphenyl ether (cordyol C) from the fungus Cordyceps sp, and performed cytotoxic tests with all three substances in two different cell lines (BC -breast cancer, and NCI-H187 -lung cancer). They found that only cordyol C had moderate cytotoxic activity against both cell lines, with an IC 50 of 8.65μg/ml and 3.75 μg/ mL for BC and NCI-H187, respectively. Wang et al. (2006) investigated the cytotoxic activity of a new diphenyl ether called Neoplaeter isolated from the cultivated fungus Neoplaconema napellum IFB-E016. Using the MTT assay, the authors observed a significant cytotoxic activity caused by Neoplaeter in the cell line KB (epidermoid nasopharyngeal cancer) with an IC 50 of 13 μg/mL. In the present study, the IC 50 found was 50.5 μg/mL, which shows that in our conditions pestheic acid is not a potent anticancer compound. Compounds exhibiting IC 50 values <4 μg/mL are considered potent (Hall et al., 1999) .
As reported above, pestheic acid cytotoxicity was not induced by apoptosis; therefore, the cell death observed in our results may have been induced by another mechanism not assessed by this study, such as necrosis. According to Bursch et al. (2008) , necrosis results from violent environmental perturbation leading to the collapse of internal homeostasis, cell swelling, and eventually cell lysis. In fact, if diphenyl ethers enhance ROS production, cell death by necrosis should not be ruled out, since the cell membrane, cell proteins, and DNA are targets for ROS attack, which culminates in the disruption of organelle and cell integrity (Festjens et al., 2006; He et al., 2008) . Birchmeier et al. (2005) observed that necrosis was the main responsible factor for the cytotoxicity observed in human thymocytes exposed to 100 μg/ mL PBDEs 47 and 99.
The present study showed the ability of pestheic acid to induce cytotoxic and mutagenic alterations in the gastric cancer cell line PG100. Even though the cytotoxicity observed in our experimental conditions does not deem the use of pestheic acid as a compound with anticancer activity, our findings demonstrate a cell behavior in the presence of a compound whose cytotoxic and genotoxic properties are completely unknown in eukaryotic cells.
